A New Hampshire man fought for the chance at a pig kidney transplant, spending months getting into good enough shape to be part of a<a class="excerpt-read-more" href=" More ...

I’m going to be going to dialysis and being tired.” So Andrews didn’t hesitate when his doctors at Massachusetts General Hospital asked whether he would consider an experimental transplant using a ...

United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock transactions, according to a recent SEC filing. On February 3, Benkowitz sold shares ...

The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...

United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...